Comments

Cormedix Stock Price, Quotes and Forecasts

Q: What sector and industry does Cormedix (CRMD) operate in?

Cormedix is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

CRMDNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$15.72

-0.84-5.07%

At close: -

$15.70

-0.02-0.13%

After Hours: 7:51 PM EDT

Cormedix (CRMD) Forecast

News Earnings Cormedix (CRMD) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Stock Score Locked: Edge Members Only

Benzinga Rankings give you vital metrics on any stock – anytime.

Unlock Rankings

Cormedix Stock Price, Quotes and Forecasts | NASDAQ:CRMD | Benzinga

Explore Cormedix stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for CRMD.

Open	$16.89
Close	$15.72
Volume / Avg.	2.53M / 2.13M
Day Range	$15.66 - $16.89
52 Wk Range	3.61 - 17.43
Market Cap	$1.06B
P/E Ratio	66.24
Dividend Yield	-
Exchange	NASDAQ
RSI	67
Short Interest	12.73%
Days to Cover	7.44

Recent News

Applied Materials To Rally Around 28%? Here Are 10 Top Analyst Forecasts For Tuesday

Avi Kapoor

CorMedix Stock Hits New 52-Week High On Updated Guidance: The Details

CorMedix Inc (NASDAQ:CRMD) shares are hitting new 52-week highs on Monday after the company raised its sales guidance for the second quarter.

Adam Eckert

Tesla, SpartanNash, Standard BioTools And Other Big Stocks Moving Higher On Monday

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Jan

Mar

Apr

May

Jun

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.9

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$16.89
Close	$15.72
Volume / Avg.	2.53M / 2.13M
Day Range	$15.66 - $16.89
52 Wk Range	3.61 - 17.43
Market Cap	$1.06B
P/E Ratio	66.24
Dividend Yield	-
Exchange	NASDAQ
RSI	67
Short Interest	12.73%
Days to Cover	7.44

About CorMedix Inc

Sector

Health Care

Industry

Pharmaceuticals

Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic pr...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Cormedix (CRMD) stock?

You can purchase shares of Cormedix (NASDAQ:CRMD) through any online brokerage.

View our list of the best stock brokerages

Who are Cormedix (CRMD) competitors?

Other companies in Cormedix’s space includes: Theravance Biopharma (NASDAQ:TBPH), GH Research (NASDAQ:GHRS), WAVE Life Sciences (NASDAQ:WVE), Xeris Biopharma Holdings (NASDAQ:XERS) and Tarsus Pharmaceuticals (NASDAQ:TARS).

What is the forecast, or price target, for Cormedix (CRMD) stock?

Cormedix has a consensus price target of $16.33.

What is the current price for Cormedix (CRMD)?

The stock price for Cormedix (NASDAQ: CRMD) is $15.7 last updated June 24, 2025 at 7:51 PM EDT.

Does Cormedix (CRMD) pay a dividend?

There are no upcoming dividends for Cormedix.

When is Cormedix (NASDAQ:CRMD) reporting earnings?

Cormedix’s Q2 earnings are confirmed for Wednesday, August 13, 2025.

Is Cormedix (CRMD) going to split?

There is no upcoming split for Cormedix.

What sector and industry does Cormedix (CRMD) operate in?

Cormedix is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.